Kahira Pharmaceuticals Restates FY Net Profit To EGP 552.5 Million
Kahira Pharmaceuticals And Chemical Industries restated its FY net profit after tax to EGP 552.5 million and FY sales to EGP 2.51 billion.
Kahira Pharmaceuticals And Chemical Industries restated its FY net profit after tax to EGP 552.5 million and FY sales to EGP 2.51 billion.